The briefing
OncoDaily highlights ten key abstracts to watch at ESMO Breast Cancer 2026, spanning HER2-targeted strategies, antibody–drug conjugates, SERDs, ctDNA and germline testing. The selections signal evolving standards and precision approaches in breast oncology.
Original headline
Top 10 Breast Cancer Abstracts To Watch At ESMO Breast Cancer 2026